Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:08 AM
Ignite Modification Date:
2025-12-25 @ 12:08 AM
NCT ID:
NCT05228158
Eligibility Criteria:
Inclusion Criteria:
1. Participants with relapsed or refractory follicular lymphoma with EZH2 gene mutation
2. Participants treated with tazemetostat
Exclusion Criteria:
1\. Participants with a history of hypersensitivity to any ingredient of Tazverik
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT05228158
Study Brief:
Protocol Section:
NCT05228158